Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 607042

Novel Spirotetracyclic Zwitterionic Dual H1/5-HT2A Receptor Antagonists for the Treatment of Sleep Disorders

Gianotti, Massimo; Botta, Maurizio; Brough, Stephen; Carletti, Renzo; Castiglioni, Emiliano; Corti, Corrado; Dal-Cin, Michele; Delle Fratte, Sonia; Korajac, Đenana; Lovrić, Marija et al.
Novel Spirotetracyclic Zwitterionic Dual H1/5-HT2A Receptor Antagonists for the Treatment of Sleep Disorders // Journal of medicinal chemistry, 53 (2010), 21; 7778-7795 doi:10.1021/jm100856p (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 607042 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Novel Spirotetracyclic Zwitterionic Dual H1/5-HT2A Receptor Antagonists for the Treatment of Sleep Disorders

Autori
Gianotti, Massimo ; Botta, Maurizio ; Brough, Stephen ; Carletti, Renzo ; Castiglioni, Emiliano ; Corti, Corrado ; Dal-Cin, Michele ; Delle Fratte, Sonia ; Korajac, Đenana ; Lovrić, Marija ; Merlo, Giancarlo ; Mesić, Milan ; Pavone, Francesca ; Piccoli, Laura ; Rast, Slavko ; Roščić, Maja ; Sava, Anna ; Šmehil, Mario ; Stasi, Luigi ; Togninelli, Andrea ; Wigglesworth, Mark J.

Izvornik
Journal of medicinal chemistry (0022-2623) 53 (2010), 21; 7778-7795

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
CNS; Sleep Disorders; H1/5-HT2A Receptor Antagonists; spirotetracyclic compound

Sažetak
Histamine H1 and serotonin 5-HT2A receptors mediate two different mechanisms involved in sleep regulation: H1 antagonists are sleep inducers, while 5-HT2A antagonists are sleep maintainers. Starting from 9′a, a novel spirotetracyclic compound endowed with good H1/5-HT2A potency but poor selectivity, very high Cli, and a poor P450 profile, a specific optimization strategy was set up. In particular, we investigated the possibility of introducing appropriate amino acid moieties to optimize the developability profile of the series. Following this zwitterionic approach, we were able to identify several advanced leads (51, 65, and 73) with potent dual H1/5-HT2A activity and appropriate developability profiles. These compounds exhibited efficacy as hypnotic agents in a rat telemetric sleep model with minimal effective doses in the range 3−10 mg/kg po.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Biologija, Temeljne medicinske znanosti



POVEZANOST RADA

Profili:

Avatar Url Milan Mesić (autor)

Avatar Url Marija Lovrić (autor)

Avatar Url Maja Roščić (autor)

Poveznice na cjeloviti tekst rada:

doi pubs.acs.org pubs.acs.org

Citiraj ovu publikaciju:

Gianotti, Massimo; Botta, Maurizio; Brough, Stephen; Carletti, Renzo; Castiglioni, Emiliano; Corti, Corrado; Dal-Cin, Michele; Delle Fratte, Sonia; Korajac, Đenana; Lovrić, Marija et al.
Novel Spirotetracyclic Zwitterionic Dual H1/5-HT2A Receptor Antagonists for the Treatment of Sleep Disorders // Journal of medicinal chemistry, 53 (2010), 21; 7778-7795 doi:10.1021/jm100856p (međunarodna recenzija, članak, znanstveni)
Gianotti, M., Botta, M., Brough, S., Carletti, R., Castiglioni, E., Corti, C., Dal-Cin, M., Delle Fratte, S., Korajac, Đ. & Lovrić, M. (2010) Novel Spirotetracyclic Zwitterionic Dual H1/5-HT2A Receptor Antagonists for the Treatment of Sleep Disorders. Journal of medicinal chemistry, 53 (21), 7778-7795 doi:10.1021/jm100856p.
@article{article, author = {Gianotti, Massimo and Botta, Maurizio and Brough, Stephen and Carletti, Renzo and Castiglioni, Emiliano and Corti, Corrado and Dal-Cin, Michele and Delle Fratte, Sonia and Korajac, \DJenana and Lovri\'{c}, Marija and Merlo, Giancarlo and Mesi\'{c}, Milan and Pavone, Francesca and Piccoli, Laura and Rast, Slavko and Ro\v{s}\v{c}i\'{c}, Maja and Sava, Anna and \v{S}mehil, Mario and Stasi, Luigi and Togninelli, Andrea and Wigglesworth, Mark J.}, year = {2010}, pages = {7778-7795}, DOI = {10.1021/jm100856p}, keywords = {CNS, Sleep Disorders, H1/5-HT2A Receptor Antagonists, spirotetracyclic compound}, journal = {Journal of medicinal chemistry}, doi = {10.1021/jm100856p}, volume = {53}, number = {21}, issn = {0022-2623}, title = {Novel Spirotetracyclic Zwitterionic Dual H1/5-HT2A Receptor Antagonists for the Treatment of Sleep Disorders}, keyword = {CNS, Sleep Disorders, H1/5-HT2A Receptor Antagonists, spirotetracyclic compound} }
@article{article, author = {Gianotti, Massimo and Botta, Maurizio and Brough, Stephen and Carletti, Renzo and Castiglioni, Emiliano and Corti, Corrado and Dal-Cin, Michele and Delle Fratte, Sonia and Korajac, \DJenana and Lovri\'{c}, Marija and Merlo, Giancarlo and Mesi\'{c}, Milan and Pavone, Francesca and Piccoli, Laura and Rast, Slavko and Ro\v{s}\v{c}i\'{c}, Maja and Sava, Anna and \v{S}mehil, Mario and Stasi, Luigi and Togninelli, Andrea and Wigglesworth, Mark J.}, year = {2010}, pages = {7778-7795}, DOI = {10.1021/jm100856p}, keywords = {CNS, Sleep Disorders, H1/5-HT2A Receptor Antagonists, spirotetracyclic compound}, journal = {Journal of medicinal chemistry}, doi = {10.1021/jm100856p}, volume = {53}, number = {21}, issn = {0022-2623}, title = {Novel Spirotetracyclic Zwitterionic Dual H1/5-HT2A Receptor Antagonists for the Treatment of Sleep Disorders}, keyword = {CNS, Sleep Disorders, H1/5-HT2A Receptor Antagonists, spirotetracyclic compound} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.